Literature DB >> 3035451

Long-term results of proton beam irradiated uveal melanomas.

E S Gragoudas, J M Seddon, K Egan, R Glynn, J Munzenrider, M Austin-Seymour, M Goitein, L Verhey, M Urie, A Koehler.   

Abstract

The first 128 consecutive patients with uveal melanomas treated with proton beam irradiation were studied in order to evaluate survival and visual acuity status of patients with relatively long-term follow-up. The median follow-up was 5.4 years, and no patient was lost to follow-up. All tumors showed regression. The most recent visual acuity was 20/40 or better in 35% and 20/100 or better in 58%. Eight eyes were enucleated because of complications. Metastasis developed in 26 patients (20.5%) from 3 months to 7 years after treatment. Results indicate that proton irradiation is quite successful for achieving local control of uveal melanomas. A large proportion of the treated eyes maintained useful vision. Five-year follow-up data indicate that proton irradiation has no deleterious effect on the likelihood of the development of metastasis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035451     DOI: 10.1016/s0161-6420(87)33456-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

Review 1.  Management of intraocular melanoma.

Authors:  W S Foulds
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

2.  Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

Review 3.  Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review.

Authors:  W A Manschot; R van Strik
Journal:  Int Ophthalmol       Date:  1992-03       Impact factor: 2.031

4.  Uveal melanoma management.

Authors:  D H Char; E S Gragoudas; T L Phillips
Journal:  Br J Ophthalmol       Date:  1989-06       Impact factor: 4.638

5.  Proton therapy for uveal melanomas and other eye lesions.

Authors:  J E Munzenrider
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

6.  Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy.

Authors:  D H Char; S Kroll; J M Quivey; J Castro
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

7.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

8.  Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland.

Authors:  Samir Aziz; Alex Taylor; Andrzej McConnachie; Alex Kacperek; Ewan Kemp
Journal:  Clin Ophthalmol       Date:  2009-06-02

9.  Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.

Authors:  H Klaus; P K Lommatzsch; U Fuchs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

10.  Predictive factors of visual outcome after local resection of choroidal melanoma.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.